Education
A novel CETP inhibitor to target cardiovascular risk reduction: where could it fit in lipid management?
Status Accredited CME, European programme
A European activity asking the practical question a clinician will ask on the day of approval: where does this sit relative to ezetimibe, bempedoic acid and the PCSK9 pathway. An example of a placement-focused programme.
With a European approval decision pending, the where-does-it-fit question is the one worth funding. It is also the question this site's guidelines section cannot answer yet, since no guideline carries the class.
Listed here as a third-party example. cetpinhibition.org does not host or accredit it.
the classguidelinesobicetrapib
Page updated 21 August 2026.